Amalgamated Bank boosted its holdings in Avanos Medical Inc (NYSE:AVNS) by 9.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Co
Avanos Medical (NYSE:AVNS) had its target price lowered by Morgan Stanley from $32.00 to $29.00 in a report published on Friday morning, AnalystRatings.com reports. The brokerage currently has a sell
Equities analysts expect Avanos Medical Inc (NYSE:AVNS) to post earnings of $0.17 per share for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for
In a report released today, David Lewis from Morgan Stanley maintained a Sell rating on Avanos Medical (AVNS), with a price target of $29.00. The
In a report released today, David Lewis from Morgan Stanley maintained a Sell rating on Avanos Medical ( AVNS – Research Report ), with a price target of $29.00 . The company’s shares closed last
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Blueshift Asset Management LLC purchased a new position in shares of Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Citigroup Inc. increased its position in shares of Avanos Medical Inc (NYSE:AVNS) by 208.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &
Great West Life Assurance Co. Can acquired a new position in Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and E
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...
Prudential Financial Inc. grew its stake in Avanos Medical Inc (NYSE:AVNS) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional inv
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
In 2017 Joe Woody was appointed CEO of Avanos Medical, Inc. (NYSE:AVNS). This report will, first, examine the CEO...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE